Medical Billing Services in AI Search: The Biggest AI Visibility Problems and How We'd Fix Them

Companies covered: CureMD, R1 RCM, DrChrono, Medusind, CareCloud, AdvancedMD, athenahealth, Tebra (Kareo), eClinicalWorks, Greenway Health

Answer Capsule

The November 2026 Medical Billing Services benchmark compares 10 companies across 479 AI answers that met its inclusion rules. athenahealth recorded 461 mentions and 308 recommendations (64.30% of the answers). Being mentioned means appearing in an answer; being recommended means receiving an affirmative endorsement.

We examine each company, compare the available monthly results, and set out a five-step plan for improving the information AI systems can draw on. The work starts with measuring visibility and checking conflicting claims, then moves to company pages, relevant publishers and buyer questions. The cited pages need review before any correction request, and the research does not establish what caused recommendation differences or promise future gains.

Executive industry diagnosis

Questions This Section Answers

• What does the Medical Billing Services benchmark show about mentions, recommendations and placement?

The peer set splits into a clear top tier and a long tail. athenahealth leads on every measure, while Tebra (Kareo) and AdvancedMD form a strong second group with similar mention and recommendation reach. eClinicalWorks is mentioned nearly as often as those two but is endorsed less often, so its visibility is broader than its endorsement.

Mid-table firms show the widest gap between being named and being endorsed. CareCloud and DrChrono appear in many answers yet draw far fewer recommendations, and their top-three placements are modest. For these companies the opportunity is less about being seen and more about being the answer a buyer is told to choose. R1 RCM and CureMD sit lower on reach but hold a meaningful share of recommendations relative to their mentions, which suggests concentrated rather than broad presence.

Greenway Health and Medusind remain marginal in this sample, so each company needs a different starting move rather than one shared playbook.

What changed since last month

Questions This Section Answers

• What changed across the usable monthly Medical Billing Services snapshots?

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

The monthly figures come from separate answer samples, so the movement should be read as recorded change rather than like-for-like performance. Several companies show higher recommendation rates in the latest month even where raw counts fell, which is a pattern worth watching but not a proven trend.

CareCloud stands out for growth in both mentions and recommendations across the recent months. athenahealth, Tebra (Kareo) and AdvancedMD remain consistently prominent. Because the samples differ, we would treat these as directional signals and confirm them against a stable baseline before drawing conclusions.

Company-by-company findings

CureMD

Questions This Section Answers

• What measured visibility pattern and review priority does CureMD have in Medical Billing Services?

CureMD recorded 86 mentions (17.95%) and 73 recommendations (15.24%) across 479 answers included in the benchmark. Top 3 placements numbered 18; first-place recommendations numbered 3. Framing among its mentions was 73 positive, 13 neutral and 0 negative.

From October 2026 to November 2026, CureMD's mention count fell from 93 to 86, while its recommendation count rose from 72 to 73. The recommendation rate was 12.18% and 15.24% respectively.

AI answers contained 0 conflicting claims about CureMD: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://curemd.com/top-ehr-vendors/.

Selected third-party review candidate: https://salesforce.com/healthcare/providers/medical-billing-software/.

CureMD is named far more often than it is placed at the top, and its recommendations are close to its mention count, which points to reach without strong positioning. The recorded movement between months is modest and comes from different samples, so we would not read it as momentum.

We would propose a conditional review of the selected owned page and the third-party source, checking current facts before any edit. A short scorecard tracking where CureMD is named versus endorsed would clarify whether the gap is a positioning issue or a content one.

R1 RCM

Questions This Section Answers

• What measured visibility pattern and review priority does R1 RCM have in Medical Billing Services?

R1 RCM recorded 103 mentions (21.50%) and 87 recommendations (18.16%) across 479 answers included in the benchmark. Top 3 placements numbered 48; first-place recommendations numbered 31. Framing among its mentions was 89 positive, 14 neutral and 0 negative.

From October 2026 to November 2026, R1 RCM's mention count fell from 111 to 103, while its recommendation count fell from 91 to 87. The recommendation rate was 15.40% and 18.16% respectively.

AI answers contained 0 conflicting claims about R1 RCM: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://r1rcm.com/about.

Selected third-party review candidate: https://keragon.com/blog/revenue-cycle-management-companies.

R1 RCM draws a healthy share of recommendations relative to its mentions and holds a notable number of first-place positions, so its presence is concentrated where it counts. The recent month shows fewer mentions and recommendations, but the samples differ and the change should not be read as a trend.

We would propose verifying the selected owned and third-party pages against current primary sources, then preparing a page brief only if a factual gap is confirmed. A scorecard separating reach from placement would help track whether R1 RCM's concentrated strength holds.

DrChrono

Questions This Section Answers

• What measured visibility pattern and review priority does DrChrono have in Medical Billing Services?

DrChrono recorded 213 mentions (44.47%) and 136 recommendations (28.39%) across 479 answers included in the benchmark. Top 3 placements numbered 33; first-place recommendations numbered 5. Framing among its mentions was 147 positive, 66 neutral and 0 negative.

From October 2026 to November 2026, DrChrono's mention count fell from 238 to 213, while its recommendation count fell from 144 to 136. The recommendation rate was 24.37% and 28.39% respectively.

AI answers contained 1 conflicting claim about DrChrono: 0 critical, 1 high, 0 medium, 0 low. Of these, 1 was rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://drchrono.com/.

Selected third-party review candidate: https://businessnewsdaily.com/16245-drchrono-medical-software.html.

DrChrono is mentioned widely but recommended far less often, and its top placements are limited, so it is visible without being the preferred choice. One high-priority conflict concerns whether it is a CRM, which is the kind of ambiguity that can shape how buyers read the product.

We would propose a fact-check of that claim against current primary sources before any correction, plus a review of the selected owned and third-party pages. A buyer-question brief on small-practice fit would target where DrChrono already appears.

Medusind

Questions This Section Answers

• What measured visibility pattern and review priority does Medusind have in Medical Billing Services?

Medusind recorded 2 mentions (0.42%) and 2 recommendations (0.42%) across 479 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 2 positive, 0 neutral and 0 negative.

From October 2026 to November 2026, Medusind's mention count fell from 3 to 2, while its recommendation count rose from 1 to 2. The recommendation rate was 0.17% and 0.42% respectively.

AI answers contained 0 conflicting claims about Medusind: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected third-party review candidate: https://pyramidsglobal.com/top-medical-billing-companies-in-usa/.

Medusind appears only rarely in this sample, and its few mentions are all positive, so the signal is thin but not negative. With no top placements recorded, there is little to interpret beyond a small, favorable presence.

We would not prioritize a correction here. Instead, we would propose a light review of the selected third-party source and a scorecard entry to watch whether Medusind's presence grows in future samples before committing content work.

CareCloud

Questions This Section Answers

• What measured visibility pattern and review priority does CareCloud have in Medical Billing Services?

CareCloud recorded 183 mentions (38.20%) and 148 recommendations (30.90%) across 479 answers included in the benchmark. Top 3 placements numbered 74; first-place recommendations numbered 15. Framing among its mentions was 153 positive, 30 neutral and 0 negative.

From October 2026 to November 2026, CareCloud's mention count rose from 134 to 183, while its recommendation count rose from 105 to 148. The recommendation rate was 17.77% and 30.90% respectively.

AI answers contained 0 conflicting claims about CareCloud: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://carecloud.com/top-medical-billing-companies/.

Selected third-party review candidate: https://daidu.ai/products/carecloud-ai.

CareCloud shows strong reach and a solid recommendation share, with a meaningful number of top placements. Its mentions and recommendations both rose in the latest month, though the samples differ, so we would treat the direction as encouraging rather than proven.

We would propose reviewing the selected owned page and third-party source against current facts, then preparing a page brief that reinforces the questions where CareCloud already appears. A scorecard tracking endorsement against reach would show whether the recent movement persists.

AdvancedMD

Questions This Section Answers

• What measured visibility pattern and review priority does AdvancedMD have in Medical Billing Services?

AdvancedMD recorded 290 mentions (60.54%) and 201 recommendations (41.96%) across 479 answers included in the benchmark. Top 3 placements numbered 121; first-place recommendations numbered 27. Framing among its mentions was 214 positive, 75 neutral and 1 negative.

From October 2026 to November 2026, AdvancedMD's mention count fell from 337 to 290, while its recommendation count fell from 224 to 201. The recommendation rate was 37.90% and 41.96% respectively.

AI answers contained 3 conflicting claims about AdvancedMD: 0 critical, 2 high, 1 medium, 0 low. Of these, 2 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://advancedmd.com/.

Selected third-party review candidate: https://tebra.com/theintake/getting-paid/how-much-does-medical-billing-software-cost.

AdvancedMD holds strong reach and a high recommendation share, with many top placements, placing it among the most endorsed firms in the set. Two high-priority conflicts concern monthly pricing, which is exactly the kind of detail that can sway a buyer comparing options.

We would propose verifying the pricing claims against current primary sources before any correction, then reviewing the selected owned and third-party pages. A pricing-focused buyer brief would address the question where the conflict appears, with qualifications kept beside the claim.

athenahealth

Questions This Section Answers

• What measured visibility pattern and review priority does athenahealth have in Medical Billing Services?

athenahealth recorded 461 mentions (96.24%) and 308 recommendations (64.30%) across 479 answers included in the benchmark. Top 3 placements numbered 248; first-place recommendations numbered 118. Framing among its mentions was 348 positive, 113 neutral and 0 negative.

From October 2026 to November 2026, athenahealth's mention count fell from 541 to 461, while its recommendation count fell from 321 to 308. The recommendation rate was 54.31% and 64.30% respectively.

AI answers contained 3 conflicting claims about athenahealth: 0 critical, 0 high, 2 medium, 1 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://athenahealth.com/.

Selected third-party review candidate: https://keragon.com/blog/revenue-cycle-management-companies.

athenahealth leads the peer set on reach, recommendations and top placements by a wide margin, so its challenge is defending a strong position rather than building one. Its recorded conflicts are lower severity, touching ownership and clinician counts, and none are rated critical or high.

We would propose confirming those details against current primary sources before any correction, then reviewing the selected owned and third-party pages. A scorecard that tracks endorsement separately from reach would help protect the lead without overreacting to small monthly shifts.

Tebra (Kareo)

Questions This Section Answers

• What measured visibility pattern and review priority does Tebra (Kareo) have in Medical Billing Services?

Tebra (Kareo) recorded 295 mentions (61.59%) and 209 recommendations (43.63%) across 479 answers included in the benchmark. Top 3 placements numbered 108; first-place recommendations numbered 28. Framing among its mentions was 227 positive, 68 neutral and 0 negative.

From October 2026 to November 2026, Tebra (Kareo)'s mention count fell from 345 to 295, while its recommendation count fell from 228 to 209. The recommendation rate was 38.58% and 43.63% respectively.

AI answers contained 3 conflicting claims about Tebra (Kareo): 0 critical, 2 high, 1 medium, 0 low. Of these, 2 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://tebra.com/.

Selected third-party review candidate: https://helcim.com/guides/healthcare-billing-software-costs/.

Tebra (Kareo) pairs strong reach with a high recommendation share and a solid number of top placements, making it one of the most endorsed firms in the set. Two high-priority conflicts concern monthly pricing, a detail buyers weigh closely when comparing vendors.

We would propose verifying the pricing claims against current primary sources before any correction, then reviewing the selected owned and third-party pages. A pricing-focused buyer brief would address the question where the conflict appears, with the qualification kept beside the claim.

eClinicalWorks

Questions This Section Answers

• What measured visibility pattern and review priority does eClinicalWorks have in Medical Billing Services?

eClinicalWorks recorded 306 mentions (63.88%) and 163 recommendations (34.03%) across 479 answers included in the benchmark. Top 3 placements numbered 70; first-place recommendations numbered 5. Framing among its mentions was 200 positive, 106 neutral and 0 negative.

From October 2026 to November 2026, eClinicalWorks' mention count fell from 361 to 306, while its recommendation count fell from 164 to 163. The recommendation rate was 27.75% and 34.03% respectively.

AI answers contained 0 conflicting claims about eClinicalWorks: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://eclinicalworks.com/.

Selected third-party review candidate: https://storage.googleapis.com/dqjwugscaueuye/how-to-create-template-on-eclinicalworks.html.

eClinicalWorks is mentioned nearly as often as the leading group but is recommended far less often, and its top placements are limited. That gap between being named and being chosen is the central issue for this company.

We would propose a review of the selected owned and third-party pages to check whether current content supports the questions where eClinicalWorks appears. A scorecard separating reach from endorsement would show whether the gap narrows, and a buyer brief could target the questions already drawing mentions.

Greenway Health

Questions This Section Answers

• What measured visibility pattern and review priority does Greenway Health have in Medical Billing Services?

Greenway Health recorded 56 mentions (11.69%) and 22 recommendations (4.59%) across 479 answers included in the benchmark. Top 3 placements numbered 2; first-place recommendations numbered 1. Framing among its mentions was 24 positive, 32 neutral and 0 negative.

From October 2026 to November 2026, Greenway Health's mention count rose from 47 to 56, while its recommendation count rose from 18 to 22. The recommendation rate was 3.05% and 4.59% respectively.

AI answers contained 0 conflicting claims about Greenway Health: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://greenwayhealth.com/resources/insights/medical-practice-management-software-a-complete-guide.

Selected third-party review candidate: https://beckershospitalreview.com/healthcare-information-technology/ehrs/25-largest-systems-ehr-vendors/.

Greenway Health has modest reach and few recommendations, with almost no top placements, so its presence is limited and largely neutral in tone. Its mentions and recommendations both rose slightly in the latest month, though the samples differ.

We would propose reviewing the selected owned page and the two third-party sources to confirm current facts before any edit. A scorecard entry would track whether the recent movement continues, and a buyer brief on EHR and EMR list questions would target where Greenway already appears.

The CiteWorks five-step improvement plan

Step 1. Establish the baseline

Questions This Section Answers

• What should the agency deliver when it works to establish the baseline for Medical Billing Services?

We would build a cohort scorecard that records each company's reach, endorsement and placement as separate measures, with the sample month noted beside every figure. This gives the client a traceable baseline and makes clear that future comparisons rest on different answer samples.

Each record would carry an owner, an evidence requirement and a review status, so later work can be checked against the same standard rather than rebuilt from scratch.

Step 2. Verify disputed facts

Questions This Section Answers

• What should the agency deliver when it works to verify disputed facts for Medical Billing Services?

AI answers contained 10 conflicting claims across 4 companies. Another 0 possible conflicts were excluded because their company matches were uncertain. The conflicting claims need fact-checking before any corrections are proposed.

The recorded conflicts cluster around pricing, ownership and product category, and they need checking against current primary sources before anyone proposes a correction. A citation or an AI claim does not by itself establish that a company or publisher made an error.

We would log each disputed claim with its source, date and resolution status, and keep ambiguous company matches outside the correction queue until the entity is confirmed.

Step 3. Review owned pages

Questions This Section Answers

• What should the agency deliver when it works to review owned pages for Medical Billing Services?

We would assign page briefs to the selected owned URLs, starting with the pages most closely tied to disputed claims and observed questions. Each brief would specify the facts to confirm, the questions to answer and the evidence required before any edit.

No page change would proceed on the strength of an AI answer alone; current primary-source verification comes first, and the brief records what was confirmed.

Step 4. Review third-party sources

Questions This Section Answers

• What should the agency deliver when it works to review third-party sources for Medical Billing Services?

For the selected third-party sources, we would prepare evidence-backed review packages rather than assume an error exists. Each package would state the specific claim, the supporting primary evidence and the requested change, and would be sent only after the source's current contents are checked.

We would track requests and responses separately, so a request is never mistaken for a confirmed correction.

Step 5. Address buyer questions and measure again

Questions This Section Answers

• What should the agency deliver when it works to address buyer questions and measure again for Medical Billing Services?

We would turn the observed buyer questions into content briefs, focusing on the questions where each company already appears. These briefs would address pricing, fit and category questions directly, with qualifications kept beside any disputed claim.

We would then measure again on a fresh sample, recording delivered work separately from answer outcomes so that completed briefs are not presented as proven gains.

Third-party authority and citation opportunities

Questions This Section Answers

• Which cited publisher pages support targeted source review in Medical Billing Services?

These pages are candidates for review, not confirmed errors. Citation appearances are counted across the captured answers and are not added again for each company.

The publisher list should be prioritized by how often each page is cited and how many of the client's companies it covers, not by citation count alone. Pages that appear repeatedly and span several companies are the most efficient places to start a review.

A citation does not establish that a page influenced an answer, so each candidate needs its current contents checked before any request. We would group the pages by company coverage, confirm the facts each one states, and only then decide whether a review request is justified.

What we'd prioritize first

The first priority is a stable baseline, because the monthly samples differ and several apparent movements need a fixed reference before they can be interpreted. Alongside it, the pricing and category conflicts deserve early fact-checking, since they touch questions buyers ask directly.

Next comes the page and source shortlist, where current contents must be verified before any edit or request. Only after those checks would we move to buyer-content briefs and a fresh scorecard, keeping completed work separate from measured outcomes.

Methodology and conclusion

Questions This Section Answers

• What do the Medical Billing Services sample and source-review limits allow us to conclude?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 479 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 4994 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reliable results for August 2026 are unavailable. This is a gap in the history, not a result of zero.

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

This report covers a single month drawn from a defined set of answers, and the exact collection dates for the original AI responses have not been verified. The visibility figures rest on answers that met the benchmark's inclusion rules, and a company counts as recommended only when an answer both endorses it and uses positive wording.

Because an answer can name several companies, company counts cannot be added to find distinct answers, and the monthly samples differ. The comparisons show how recorded results changed, not why. Proposed next steps are reviews and briefs to be verified against current primary sources, not promises of improved placement.